We are live on ! Find out more
JO

John Overdeck Two Sigma Investments

AUM $138B
1-Year Est. Return 41.87%
 

John Overdeck is a co-founder of Two Sigma Investments, one of the world’s leading quantitative and technology-driven investment firms. Two Sigma applies data science, machine learning, and large-scale computing to markets across asset classes. Overdeck’s firm is a central reference point in discussions of modern systematic investing.

This Fund
S&P 500
This Quarter Est. Return
-17.54%
1 Year Est. Return
+41.87%
3 Year Est. Return
+122.61%
5 Year Est. Return
+129.48%
10 Year Est. Return
+649.67%
AUM
$30.3B
AUM Growth
-$3.58B
Cap. Flow
+$2.33B
Cap. Flow %
7.68%
Top 10 Hldgs %
8.23%
Holding
3,177
New
628
Increased
764
Reduced
970
Closed
730

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$297M
2
BAC icon
Bank of America
BAC
+$249M
3
ORCL icon
Oracle
ORCL
+$247M
4
MSFT icon
Microsoft
MSFT
+$246M
5
SNAP icon
Snap
SNAP
+$243M

Top Sells

Rank Stock Value
1
TSLA icon
Tesla
TSLA
+$260M
2
MRK icon
Merck
MRK
+$260M
3
SPGI icon
S&P Global
SPGI
+$233M
4
OXY icon
Occidental Petroleum
OXY
+$221M
5
WMT icon
Walmart Inc
WMT
+$211M

Sector Composition

Rank Sector Weight
1 Technology 19.21%
2 Healthcare 13.54%
3 Financials 11.06%
4 Industrials 10.41%
5 Consumer Discretionary 7.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SOPH icon
2326
SOPHiA GENETICS
SOPH
$719M
$49K ﹤0.01%
+13,646
New +$69.2K
CALA
2327
DELISTED
Calithera Biosciences, Inc
CALA
$49K ﹤0.01%
19,947
-22,327
-53% -$104K
SEGG
2328
Sports Entertainment Gaming Global Corp
SEGG
$8.25M
$48K ﹤0.01%
+31
New +$80.8K
SLS icon
2329
SELLAS Life Sciences
SLS
$2.89B
$48K ﹤0.01%
+21,494
New +$63K
FCRD
2330
DELISTED
First Eagle Alternative Capital BDC, Inc. Common Stock
FCRD
$48K ﹤0.01%
13,464
-8,065
-37% -$31.6K
VTGN icon
2331
VistaGen Therapeutics
VTGN
$10.8M
$47K ﹤0.01%
1,778
-11,109
-86% -$392K
ASRV icon
2332
AmeriServ Financial
ASRV
$81.7M
$46K ﹤0.01%
11,769
-300
-2% -$1.2K
APRE icon
2333
Aprea Therapeutics
APRE
$10.1M
$45K ﹤0.01%
3,019
+2,088
+224% +$48.1K
LRMR icon
2334
Larimar Therapeutics
LRMR
$421M
$45K ﹤0.01%
22,712
-5,700
-20% -$16.8K
LEV
2335
DELISTED
The Lion Electric Company
LEV
$45K ﹤0.01%
+10,705
New +$62.8K
SQZ
2336
DELISTED
SQZ Biotechnologies Company
SQZ
$44K ﹤0.01%
13,732
-25,960
-65% -$93.4K
LSF icon
2337
Laird Superfood
LSF
$42.2M
$42K ﹤0.01%
21,823
-47,450
-68% -$130K
GP
2338
GreenPower Motor Co
GP
$14.3M
$41K ﹤0.01%
+1,228
New +$64K
RVSN icon
2339
Rail Vision
RVSN
$11.5M
$40K ﹤0.01%
+185
New +$58.6K
ZSTK
2340
ZeroStack Corp
ZSTK
$88.5M
$37K ﹤0.01%
+78
New +$74K
IMNN icon
2341
Imunon
IMNN
$8.92M
$37K ﹤0.01%
1,524
-1,199
-44% -$43.9K
AMBR
2342
Amber International Holding Ltd
AMBR
$102M
$37K ﹤0.01%
5,554
-8,226
-60% -$68.1K
HARP
2343
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
$37K ﹤0.01%
+1,921
New +$49.8K
SOUN icon
2344
SoundHound AI
SOUN
$3.11B
$36K ﹤0.01%
+13,516
New +$83.5K
PEAR
2345
DELISTED
Pear Therapeutics, Inc. Class A Common Stock
PEAR
$36K ﹤0.01%
+23,224
New +$90.8K
ARC
2346
DELISTED
ARC Document Solutions, Inc.
ARC
$36K ﹤0.01%
13,567
-12,769
-48% -$41.6K
DMAC icon
2347
DiaMedica Therapeutics
DMAC
$352M
$35K ﹤0.01%
17,249
-32,819
-66% -$76.6K
BNC
2348
CEA Industries
BNC
$128M
$34K ﹤0.01%
+2,270
New +$41.2K
TOVX icon
2349
Theriva Biologics
TOVX
$10.8M
$34K ﹤0.01%
645
-8
-1% -$458
FUV
2350
DELISTED
Arcimoto, Inc. Common Stock
FUV
$34K ﹤0.01%
+515
New +$40.8K

Similar funds

John Overdeck's Q2 2022 Portfolio in Review

As of Q2 2022, John Overdeck held 3,177 positions worth $30.3B, down 11% from $33.9B the previous quarter. Its ten largest holdings account for 8.2% of the portfolio.

John Overdeck deployed $2.33B of net new capital in Q2 2022, opening 628 new positions and adding to 764 existing holdings. Its largest new stake was Meta Platforms (Facebook): 1,541,482 shares worth $249M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Merck, an estimated $260M trimmed.

  • John Overdeck's largest Q2 2022 buy was Meta Platforms (Facebook): 1,541,482 shares worth $249M.
  • John Overdeck added most to Bank of America in Q2 2022, an estimated $249M increase.
  • John Overdeck's biggest Q2 2022 reduction was Merck, cutting an estimated $260M.
  • John Overdeck fully exited Tesla in Q2 2022, selling an estimated $260M.
  • John Overdeck's ten largest holdings make up 8.2% of its $30.3B portfolio in Q2 2022.
  • John Overdeck opened 628 new positions and closed 730 in Q2 2022.
  • John Overdeck's portfolio value fell 11% quarter-over-quarter to $30.3B.

Based on Two Sigma Investments's 13F filing for Q2 2022, filed 15 Aug 2022.